Project Grant RF1AG083801
Award Date
9/1/23
Completion Date
8/31/26
Dollars Obligated
$2.4M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This $4.4 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund research into developing a non-invasive stem cell-derived extracellular vesicle therapy for Alzheimer's disease. Over a three-year period from August 2022 to July 2025, researchers at Texas A&M University Health Science Center will test the hypothesis that intranasal administration of extracellular vesicles generated from human-induced pluripotent stem...
The Johns Hopkins University has been awarded a $324,698 Project Grant from the National Institute on Aging (CFDA 93.866 - Aging Research) to study cell-free DNA as a marker of Alzheimer's disease progression and its role in chronic inflammation. The study will use digital PCR to measure cell-free DNA levels in serum samples from individuals with mild cognitive impairment and normal cognition, and evaluate associations with rates of cognitive decline. Additionally, the research will assess the...
The National Institute on Aging (NIA) awarded a Project Grant under the Aging Research program (CFDA 93.866) to The Johns Hopkins University for a $1,669,370 research project titled "The Cross-Talk Between A-Synucleinopathies and T Cell Immunity in ADRD". The project aims to investigate the progression of a-synuclein pathologies from the gut to the brain and the role of the gut-brain axis in Alzheimer's Disease and Related Dementias (ADRD). The research will also examine the impact...
This $343,440 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports a research study by Dr. Lolita Nidadavolu at the Johns Hopkins University School of Medicine. The study aims to examine the association between cell-free DNA and microglial activation in Alzheimer's disease. Specifically, the project will analyze serum samples to assess the relationship between cell-free DNA levels and microglial activation markers (Aim 1). It will also...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) in the amount of $246,750 will support the development of a novel pulse-labeling assay to track the secretion and spreading of extracellular vesicles (EVs) in the brains of mice. The award to The Trustees of Columbia University will enable the researchers to create a Halotag EV Pulse-Chase (HEVPL) assay with three key components: 1) EV-enriched tetraspanin membrane proteins conjugated to the...
This $306,509 federal Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to Captis Diagnostics Inc. aims to develop a technology platform for rapid magnetic isolation of neuronal extracellular vesicles (EVs) from blood plasma samples. The goal is to enable the detection of biomarkers for neurological diseases such as Alzheimer's, Parkinson's, and traumatic brain injury through a minimally invasive liquid biopsy approach. Key activities include developing...
This $2,365,042 Project Grant was awarded by the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866) to conduct research on the biological underpinnings of Alzheimer's disease and related dementias (ADRD). The research aims to better characterize the interplay between biological markers of neurodegeneration, vascular, nutritional, and inflammatory systems, and their interface with social and economic factors, by leveraging cross-national comparisons...
This $622,086 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to The Johns Hopkins University supports research to elucidate the role of the NOD2/RIPK2 signaling pathway in microglial activation and its implications for neuroinflammation and neurodegeneration in Alzheimer's disease (AD). The research aims to: 1) characterize the mechanisms driving microglial activation by amyloid-beta oligomers and the involvement of NOD2/RIPK2 signaling, 2) determine...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $866,723 to The Johns Hopkins University for a project titled "Multi-Scale MRI-Based Diffeomorphometry of Pathology and Molecular Signatures Associated with Entorhinal Cortex Atrophy in Alzheimer's Disease". The project aims to integrate high-field post-mortem imaging, histological, and spatial transcriptomic data to link the spatial and temporal progression of MRI markers to...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders provides $2,683,965.00 to Brigham & Women's Hospital Inc. to develop and optimize an improved all-human cellular system for studying Alzheimer's disease (AD) and age-related dementias (ADRDs). The key objectives are to: Define the delivery conditions for introducing patient blood cells and plasma...